We are pleased to invite you to attend Committee of 100’s Conversations—”Recollections, Pioneers, and Heroes” featuring award-winning playwright, librettist, screenwriter, and Columbia University professor David Henry Hwang.

Peter Young, Chair of the Conversations Initiative and Committee of 100 New York Regional Chair and Board Member, will be the moderator.

David Henry Hwang
Playwright, Librettist, Screenwriter
Obie and Tony Award Winner

David Henry Hwang is an American playwright, librettist, screenwriter, and theater professor at Columbia University in New York City. He has won three Obie Awards for his plays FOB, Golden Child, and Yellow Face. He has one Tony Award (M. Butterfly) and three other nominations (Golden Child, Flower Drum Song, and Yellow Face), as well as a Grammy Award (Ainadamar) and one other nomination (Soft Power). Three of his works (M. Butterfly, Yellow Face, and Soft Power) have been finalists for the Pulitzer Prize for Drama.

Peter Young
CEO and President of Young & Partners;
Committee of 100 New York Regional Chair and Board Member

Peter Young is CEO of Young & Partners, a boutique investment banking firm focused on the life science and chemical industries. He manages the firm and is actively involved in client transactions and financings. Under his leadership, Young & Partners has established and maintained its position as a highly regarded firm serving the corporate strategy, M&A, restructuring and financing needs of clients worldwide. He was previously head of industry groups at Salomon Brothers, Schroders and Lehman Brothers, a senior private equity executive with J.H. Whitney & Co. and a senior member of Bain & Co., the corporate strategy firm.

Young received a BA in Economics from Yale, an MS in Accounting from NYU, and MBA from Harvard Business School where he graduated with Distinction as a Baker Scholar. He is a CPA and a Chartered Global Management Accountant. He serves on a number of boards of directors, both corporate and non-profit and is a board member of Société de Chimie Industrielle, a leading life science and chemical industry non-profit organization and on the Editorial Advisory Board of Pharmaceutical Executive.